TL;DR: 20n is a Y Combinator Winter 2015 startup Using AI to predict biochemistry for manufacturing and therapeutics, currently inactive with a team of 2.
Using AI to predict biochemistry for manufacturing and therapeutics
Last verified:
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data learning problem, and bring to bear techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. With the support of DARPA [2], we are building a team of computer scientists, and bioengineers to look at biology in fundamentally…
Built by LemStudio
Yes. 20n was funded by Y Combinator in the Winter 2015 batch. Using AI to predict biochemistry for manufacturing and therapeutics
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that p…
20n was part of Y Combinator's Winter 2015 batch.
20n has a team of 2 people according to Y Combinator's directory.
20n is currently listed as Inactive with a team of 2 in Y Combinator's directory.
Loading interactive view…